RIL
FOLD

Rothschild Investment LLC’s Amicus Therapeutics FOLD Stock Holding History

Rothschild Investment LLC’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-635
Closed -$9.18K – 3674
2026
Q1 		$9.18K Buy
635
+103
+19% +$1.48K ﹤0.01% 1728
2025
Q4 		$7.58K Buy
532
+142
+36% +$1.4K ﹤0.01% 1693
2025
Q3 		$3.07K Buy
390
+200
+105% +$1.42K ﹤0.01% 1964
2025
Q2 		$1.09K Sell
190
-90
-32% -$581 ﹤0.01% 2427
2025
Q1 		$2.29K Buy
280
+60
+27% +$555 ﹤0.01% 1811
2024
Q4 		$2.07K Sell
220
-70
-24% -$728 ﹤0.01% 1778
2024
Q3 		$3.1K Buy
290
+155
+115% +$1.69K ﹤0.01% 1491
2024
Q2 		$1.34K Buy
135
+105
+350% +$1.08K ﹤0.01% 1526
2024
Q1 		$353 Buy
+30
New +$384 ﹤0.01% 1488

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rothschild Investment LLC's FOLD Position: Q2 2026 in Review

Rothschild Investment LLC sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 635 shares — an estimated $9.18K sold.

Rothschild Investment LLC first reported a position in FOLD in Q1 2024 and held it in 9 quarters. The position peaked at $9.18K in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

  • Rothschild Investment LLC reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Rothschild Investment LLC sold 635 Amicus Therapeutics shares in Q2 2026, an estimated $9.18K.
  • Rothschild Investment LLC first reported a position in Amicus Therapeutics in Q1 2024 and held it in 9 quarters.
  • Rothschild Investment LLC's Amicus Therapeutics position peaked at $9.18K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.